About ResMed
ResMed is a company based in San Diego (United States) founded in 1989 by Peter Farrell. The company has 10,600 employees as of June 30, 2025. ResMed has completed 15 acquisitions, including BiancaMed, Brightree and Curative Medical. ResMed offers products and services including CPAP Devices, CPAP Masks, and myAir App. ResMed operates in a competitive market with competitors including ProSomnus, AeroCare Holdings, BMC Medical, Sommetrics and ApniCure, among others.
- Headquarter San Diego, United States
- Employees 10600 as on 30 Jun, 2025
- Founders Peter Farrell
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Resmed Inc.
-
Annual Revenue
$5.15 B (USD)9.84as on Jun 30, 2025
-
Net Profit
$1.4 B (USD)37.2as on Jun 30, 2025
-
EBITDA
$1.92 B (USD)20.18as on Jun 30, 2025
-
Latest Funding Round
$500 M (USD), Debt – Conventional
Jul 15, 2019
- Investors
-
Employee Count
10600
as on Jun 30, 2025
-
Investments & Acquisitions
BiancaMed
& 14 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ResMed
ResMed is a publicly listed company on the NYSE with ticker symbol RMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ResMed
ResMed offers a comprehensive portfolio of products and services, including CPAP Devices, CPAP Masks, and myAir App.
Devices that deliver continuous positive airway pressure for sleep apnoea treatment.
Masks designed for secure fit during CPAP therapy sessions.
App for monitoring and managing patient therapy progress remotely.
People of ResMed
Unlock access to complete
Unlock access to complete
Software Development Team
169 people
Sales and Marketing
79 people
Senior Team
54 people
Leadership Team
54 people
Human Resources and Administration
46 people
Data Analysis and Operations Team
38 people
Product Management Team
35 people
Finance and Accounting
28 people
Unlock access to complete
Funding Insights of ResMed
Investors in ResMed
ResMed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Mirrabooka Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SME foused PE firm investing in Australia and New Zealand
|
Locked | Locked | Locked |
Investor details for ResMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ResMed
ResMed has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include BiancaMed, Brightree and Curative Medical.
Investment portfolio details for ResMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of connected solutions for monitoring sleep disorders
|
Locked | Locked | 2015 | Locked | |
|
Integrated care delivery and analytics platform for sleep disorder management
|
Locked | Locked | 2013 | Locked | |
|
Provides a care management digital platform which enables patients to be cared for outside of hospital wall.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for ResMed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - ResMed
Detailed financials for ResMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resmed Comparisons
Peer comparison for ResMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ResMed
ResMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProSomnus, AeroCare Holdings, BMC Medical, Sommetrics and ApniCure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Lower jaw advancement devices for obstructive sleep apnea are developed.
|
|
| Locked | Locked | Locked |
Provider of medical devices for obstructive respiratory diseases and sleep apnea
|
|
| Locked | Locked | Locked |
Respiratory devices including ventilators, masks, and oxygen therapy are manufactured.
|
|
| Locked | Locked | Locked |
Sommetrics is focused on diagnosing, treating and monitoring Obstructive Sleep Effect.
|
|
| Locked | Locked | Locked |
Home-use devices for sleep apnea treatment are developed and commercialized.
|
Detailed competitors of ResMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resmed
Complete news archive for ResMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ResMed
ResMed was founded in 1989 and raised its 1st funding round 27 years after it was founded.
ResMed is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Jun 30, 2025, the latest employee count at ResMed is 10,600.
Annual revenue of ResMed is $5.15B as on Jun 30, 2025.
Therapeutic devices to treat sleep apnea and respiratory disorders. The companys products include Masks (Nasal pillows, Nasal masks, Full-face masks, Paediatric masks, and Non-vented masks), Devices (Range of CPAP, VPAP, Ventilators, etc), Humidifiers, and Accessories. The company developed a non-contact sleep tracking system that helps users analyze and improve sleep. The system records the light, noise, and temperature conditions in the room, and syncs with smartphones to provide feedback and suggestions. In 2022, the company recorded annual revenues of 4.02B and a net profit of 0.86B.
ResMed's top competitors include BMC Medical, ProSomnus and React Health.
ResMed offers CPAP Devices, CPAP Masks, and myAir App.
Yes, ResMed is publicly traded on NYSE under the ticker symbol RMD.
ResMed has made 15 acquisitions, including BiancaMed, Brightree, and Curative Medical.
ResMed has 1 investor. Key investors include Mirrabooka Investments.
The ticker symbol of ResMed is RMD on NYSE.